Interview: Krebs im Blut

INTERVIEW Krebs im BLUT Due to the overwhelming response to X-ZELL’s recent Live Sessions tour around Germany, we sat down with X-ZELL Founder & CEO, Dr Sebastian Bhakdi, to interview him in his native language.  Singapur, Februar 2020 – Der deutsche Arzt Dr....

X-ZELL Cryoimmunostaining™ technology touring Europe

X-ZELL Cryoimmunostaining™ technology live in Europe Brussels, February 2020 – Following the official European launch of X-ZELL’s Cryoimmunostaining™ Suite in November 2019, the Singapore start-up will be holding a series of Live Sessions in 2020 in order to introduce...

X-ZELL to be featured at Phar-East 2020 in Singapore

X-ZELL cancer detection technology on show at Phar-East 2020 Singapore, February 2020 – X-ZELL has been selected as one of 50 start-ups to be featured at the upcoming Phar-East Summit in Singapore. To be held between 30 June and 1 July at the Resorts World Convention...

X-ZELL selected as Finalist for 2020 Hello Tomorrow Global Challenge

X-ZELL selected as Finalist for 2020 Hello Tomorrow Global Challenge Singapore, January 2020 – Singapore med tech start-up, X-ZELL, has been nominated as a Global Finalist for the 2020 Hello Tomorrow Challenge.  Considered one of the world’s leading deep tech start-up...

X-ZELL named global Deep Tech Pioneer by Hello Tomorrow

X-ZELL named Deep Tech Pioneer by Hello Tomorrow Singapore, November 2019 – On the back of qualifying for the regional final of the prestigious Hello Tomorrow Challenge, X-ZELL has now been selected as one of Hello Tomorrow’s Deep Tech Pioneers. According to the...

X-ZELL Cryoimmunostaining™ Suite now available in Europe

X-ZELL Cryoimmunostaining™ coming to Europe Singapore, November 2019 – Less than a year after premiering at Singapore’s MEDLAB Asia exhibition, X-ZELL’s Cryoimmunostaining™ Suite is now available in Europe. Originally designed to enable X-ZELL’s headline-making...